GILEAD SCIENCES INC's ticker is and the CUSIP is 375558953. A total of 13 filers reported holding GILEAD SCIENCES INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $75,295,000 | +4.4% | 902,600 | +14.9% | 0.08% | -7.7% |
| Q1 2016 | $72,156,000 | +10.8% | 785,500 | +22.1% | 0.09% | +28.2% |
| Q4 2015 | $65,106,000 | -35.8% | 643,400 | -37.7% | 0.07% | -26.0% |
| Q3 2015 | $101,470,000 | -8.6% | 1,033,400 | +9.0% | 0.10% | 0.0% |
| Q2 2015 | $110,957,000 | +73.4% | 947,700 | +45.4% | 0.10% | +57.4% |
| Q1 2015 | $63,971,000 | -38.9% | 651,900 | -41.3% | 0.06% | -40.8% |
| Q4 2014 | $104,657,000 | +43.0% | 1,110,300 | +61.5% | 0.10% | +33.8% |
| Q3 2014 | $73,163,000 | +20.8% | 687,300 | -5.9% | 0.08% | +11.6% |
| Q2 2014 | $60,582,000 | -25.7% | 730,700 | -36.5% | 0.07% | -28.1% |
| Q1 2014 | $81,560,000 | +37.8% | 1,151,000 | +46.1% | 0.10% | +24.7% |
| Q4 2013 | $59,188,000 | +40.7% | 787,600 | +17.7% | 0.08% | +20.3% |
| Q3 2013 | $42,053,000 | +19.1% | 669,200 | -2.9% | 0.06% | +4.9% |
| Q2 2013 | $35,304,000 | – | 689,400 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 371,200 | $27,817,728 | 0.09% |
| Maven Securities LTD | 34,100 | $2,555,454 | 0.03% |
| SIMPLEX TRADING, LLC | 444,600 | $33,318 | 0.03% |
| Allianz Asset Management GmbH | 171,700 | $12,867,198 | 0.02% |
| IMC-Chicago, LLC | 238,500 | $17,873,190 | 0.02% |
| JANE STREET GROUP, LLC | 152,400 | $11,420,856 | 0.00% |
| JPMORGAN CHASE & CO | 243,300 | $18,232,902 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |